Musely Launches The Age Well Pill, Named Fastest Growing Telemedicine Brand for the Second Year in a Row, and Honored as Ad Age 2025 Breakout Brand Leader

SILICON VALLEY, Calif., Sept. 17, 2025 /PRNewswire/ -- Musely, the leading innovator in telemedicine with over 1 million patients served nationwide, today announced the upcoming launch of The Age Well Pill, a groundbreaking daily longevity prescription designed to help patients age better from the inside out. Officially available beginning Friday, September 19, 2025 on musely.com, the new treatment expands Musely's portfolio beyond skincare, hair, and hormonal health into the growing field of longevity medicine.

In just six years, Musely has transformed from a tele-dermatology startup into the fastest-growing brand in telemedicine, expanding its offerings from 2 treatments to 24. This milestone reflects the company's mission to help patients not only look good but also live better. 

The announcement comes as Musely is named the fastest growing telemedicine brand for the second year in a row on the Inc. 5000 list, while also being honored as an Ad Age 2025 Breakout Brand Leader, a prestigious award for a small group of brands that made a major impact over the past year. These recognitions highlight Musely's disruptive growth model, patient-first innovation, and exceptional retention rates.

"This is the next chapter in our story," said Jack Jia, Founder and CEO of Musely. "Musely has mastered the teledermatology model, and now, with The Age Well Pill, we are helping people live stronger, healthier lives while being recognized as the fastest-growing brand in our field two years in a row."

Developed by Musely's board-certified physicians, pharmacists, and chemists, The Age Well Pill combines five of the most studied compounds in longevity science: metformin, fisetin, CoQ10, calcium alpha-ketoglutarate (Ca-AKG), and NAD+ boosters. These ingredients have been widely researched for their potential roles in supporting cellular health, energy efficiency, and overall wellness. The result is a formula designed with the goal of helping people pursue a strong, vibrant, and active life as they age.

Musely's Chief Medical Officer, Dr. Marie Jhin, explained, "This represents an exciting step forward in preventive health. We are addressing healthspan by helping patients live healthier, more energized lives."

The development of The Age Well Pill reflects Musely's broader trajectory. Since its founding, the company has dispensed over 5 million prescriptions and expanded its portfolio across dermatology, hair, women's health, and now longevity. Its combination of profitable growth, patient-focused innovation, and unmatched retention has established Musely as a true disruptor in telehealth. 

About Musely
Musely is the leading telemedicine company redefining prescription care with accessible, affordable, and effective treatments across dermatology, hair loss, hormonal health, and longevity. Founded in 2019, Musely has built a thriving community of over 1 million patients, supported by board-certified physicians and pharmacists who deliver personalized treatments straight to patients' doors. With its mission to help people look good and live better, Musely continues to push the boundaries of what telemedicine can achieve. Learn more at www.musely.com

PR Contact: 

Christie Corso, [email protected] 

SOURCE Musely